Start with the food plan, not the dose
Ketoanalogues are an adjunct to a supervised low- or very-low-protein diet with adequate energy. A dose without a written food-protein and energy prescription, a review of actual intake (including protein shakes), and a named monitoring owner does not reproduce the conditions of the trials. Patients and families: see Hold the Ketoanalogue Until You See a Nephrologist. To add up protein from food and drinks, translate an issued prescription, or total calcium, use the Ketoanalogue Plan Check.
- Select the height and weight units to match your records. Switching a unit clears that field.
- Enter age, select sex, and enter height and actual body weight. Height drives the Devine ideal body weight (IBW) used for dosing.
- Choose the diet strategy — VLPD (very-low-protein, 0.3–0.4 g/kg/day) + KA, or LPD (low-protein, 0.6 g/kg/day) ± KA.
- Choose the dosing weight (IBW is the default and is recommended) and the KA dose rate — standard Ketosteril (1 tablet per 5 kg/day) or a custom g/kg/day.
- The result shows KA tablets/day, a practical 3-times-daily schedule, and the paired dietary protein target. Confirm with a renal dietitian before prescribing.
All computation runs in your browser; no values are stored or transmitted.
When to Use
Use this tool to plan ketoacid/amino-acid analogue (KA; e.g. Ketosteril) dosing for a non-dialysis CKD patient placed on a protein-restricted diet, and to set the paired dietary protein target. KA supplements provide keto-acid carbon skeletons of essential amino acids that lack the amino group (the tablet also contains five amino acids, about 36 mg of nitrogen per tablet in the reference product), letting the patient meet amino-acid needs on a very-low-protein diet (VLPD) without generating the nitrogenous waste that drives uremic symptoms. The supplement and the diet are inseparable: dosing KA without restricting dietary protein — or restricting protein without supplementing — defeats the purpose.
Appropriate population
Adults with non-dialysis CKD (typically stage 3b–5, eGFR < 45 and especially < 30 mL/min/1.73 m²) who are nutritionally stable, motivated, and able to follow a protein-restricted diet under dietitian supervision — used to slow progression and reduce uremic symptoms. A VLPD (0.3–0.4 g/kg/day) is supplemented with KA; an LPD (0.6 g/kg/day) may be used with or without KA. Dosing weight defaults to Devine ideal body weight.
When NOT to use it
Do not start KA/VLPD in malnourished patients or those with protein-energy wasting, poor intake, or active catabolic illness. KA salts contain calcium — contraindicated in hypercalcemia and in disordered amino-acid metabolism, and used cautiously with active vitamin D and calcium-based binders. Protein intake liberalizes once the patient starts maintenance dialysis, so this restricted-diet strategy no longer applies there. Adequate energy intake (30–35 kcal/kg/day) is mandatory to prevent catabolism.
Pearls & Pitfalls
Dose by ideal body weight, take with meals
Standard Ketosteril dosing is ~1 tablet per 5 kg body weight per day (≈0.1 g/kg/day; each tablet ≈0.63 g), computed on ideal — not actual — body weight to avoid over-dosing the obese patient. Divide the daily dose across meals (3, or 3–4, times daily), swallowing tablets whole during the meal so the amino-acid skeletons are used for protein synthesis rather than energy.
The diet is half the prescription
Pair every KA prescription with an explicit protein target: VLPD 0.3–0.4 g/kg/day or LPD 0.6 g/kg/day, with ~50% from high-biological-value sources (egg, dairy, fish, lean meat). Above all, ensure 30–35 kcal/kg/day of energy — an under-fed protein-restricted patient catabolizes their own muscle, the exact harm the strategy is meant to prevent.
Pitfalls
(1) Watch for protein-energy wasting — monitor weight, albumin/prealbumin, and nutritional status; stop if intake or status declines. (2) KA contains calcium salts — monitor serum calcium and watch for hypercalcemia, especially with active vitamin D or calcium-based binders; contraindicated in hypercalcemia. (3) Contraindicated in disturbed amino-acid metabolism. (4) Not for malnourished patients. (5) Requires close renal-dietitian supervision — this calculator informs, it does not replace that supervision.
Why Use It
In non-dialysis CKD, a protein-restricted diet lowers the nitrogenous-waste and acid load on remaining nephrons, which can slow progression and reduce uremic symptoms (the KDOQI 2020 nutrition guideline supports protein restriction, with keto-analogue supplementation as an option for VLPD). Ketoanalogues let a patient go as low as 0.3–0.4 g protein/kg/day while still meeting essential amino-acid requirements, because the supplement supplies the carbon skeletons without the nitrogen. The trade-off is malnutrition risk: success depends on adequate calories, high-biological-value protein, and tight dietitian monitoring — exactly the parameters this calculator surfaces alongside the dose.
Ketoanalogue (KA) Supplement Dose Calculator
Enter age, sex, height, and weight to derive ideal body weight, choose a diet strategy and dose rate, and read the KA tablets per day, a 3-times-daily schedule, and the paired dietary protein target.
Confirm the written food prescription and monitoring owner above to see the arithmetic.
⚕ KA tablets/day = round(dosing weight ÷ 5) at the standard rate (≈0.1 g/kg/day; ~0.63 g/tablet); custom rate = round(g/kg/day × dosing weight ÷ 0.63). Dosing weight defaults to Devine IBW: men 50 + 2.3×(height in − 60); women 45.5 + 2.3×(height in − 60); Adjusted BW = IBW + 0.4×(actual − IBW). Dietary protein target (g/day) = protein g/kg/day × dosing weight. For non-dialysis CKD only; requires dietitian supervision and adequate energy (30–35 kcal/kg/day). Source: KDOQI 2020 Nutrition in CKD Update; Ketosteril prescribing information.
Next Steps
Use the result to support — not replace — a dietitian-led nutrition plan.
- Refer to a renal dietitian to build the diet around the protein target shown and confirm energy intake of 30–35 kcal/kg/day before starting.
- Aim for ~50% of dietary protein from high-biological-value sources (egg, dairy, fish, lean meat).
- Take KA tablets whole, with meals, on the schedule shown; keep total within the labelled maximum.
- Monitor body weight, albumin/prealbumin, and nutritional status for protein-energy wasting; monitor serum calcium given the calcium-salt content.
- Reassess at each visit; liberalize protein once the patient transitions to maintenance dialysis, and stop KA/VLPD if nutritional status declines.
Evidence & References
Formula & Equations
| Quantity | Equation |
|---|---|
| Ideal body weight — men (Devine) | 50 + 2.3 × (height in inches − 60) |
| Ideal body weight — women (Devine) | 45.5 + 2.3 × (height in inches − 60) |
| Adjusted body weight | IBW + 0.4 × (actual weight − IBW) |
| KA tablets/day (standard) | round(dosing weight in kg ÷ 5) (≈ 0.1 g/kg/day; ~0.63 g/tablet) |
| KA tablets/day (custom) | round(g/kg/day × dosing weight ÷ 0.63 g per tablet) |
| Dietary protein target (g/day) | protein g/kg/day × dosing weight in kg |
| SI conversion | weight (kg) = lb ÷ 2.2046; height (in) = cm ÷ 2.54 |
Diet strategies & protein targets
| Strategy | Protein | Ketoanalogue |
|---|---|---|
| VLPD + KA | 0.3–0.4 g/kg/day | Required — supplies essential amino-acid skeletons |
| LPD ± KA | 0.6 g/kg/day | Optional |
| Energy intake | 30–35 kcal/kg/day | Mandatory in both — prevents catabolism |
| High-biological-value protein | ~50% of total | Egg, dairy, fish, lean meat |
Ketosteril dosing is ~1 tablet per 5 kg body weight per day (≈0.1 g/kg/day; each tablet ≈0.63 g), divided across meals. KA salts contain calcium — monitor serum calcium. For non-dialysis CKD only; protein intake liberalizes on dialysis.
Evidence & References
The KDOQI 2020 Clinical Practice Guideline for Nutrition in CKD supports protein restriction in metabolically stable non-dialysis CKD, with keto-analogue/amino-acid-analogue supplementation as an option to allow a very-low-protein diet while preserving nutritional status. Standard Ketosteril dosing of 1 tablet per 5 kg body weight per day comes from its prescribing information. The strategy demands adequate energy intake and close monitoring for protein-energy wasting.
- Ikizler TA, Burrowes JD, Byham-Gray LD, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis. 2020;76(3 Suppl 1):S1–S107.
- Mitch WE, Remuzzi G. Diets for patients with chronic kidney disease, should we reconsider? BMC Nephrol. 2016;17:80.
- Ketosteril (ketoanalogues of essential amino acids) prescribing information (1 tablet per 5 kg body weight per day).
- Devine BJ. Gentamicin Therapy. Drug Intell Clin Pharm. 1974;8(11):650–655.
